These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9545154)

  • 1. Rifampin, a useful drug for nonmycobacterial infections.
    Vesely JJ; Pien FD; Pien BC
    Pharmacotherapy; 1998; 18(2):345-57. PubMed ID: 9545154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of bacampicillin in acute bacterial infections.
    Ogunyemi O
    Clin Ther; 1983; 5(5):472-4. PubMed ID: 6352033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin, trimethoprim-sulfamethoxazole, and rifampin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 1995 Sep; 9(3):747-67. PubMed ID: 7490442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
    Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Nathwani D
    Int J Antimicrob Agents; 2004 Mar; 23(3):240-6. PubMed ID: 15164964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I; Foote PA; Hausfeld JN
    Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives.
    Fujii K; Tsuji A; Miyazaki S; Yamaguchi K; Goto S
    Antimicrob Agents Chemother; 1994 May; 38(5):1118-22. PubMed ID: 8067748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin: a new rifamycin. I. Bacteriological studies.
    Arioli V; Pallanza R; Furesz S; Carniti G
    Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB
    Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections.
    Fritsche TR; Kirby JT; Jones RN
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):201-9. PubMed ID: 15246511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with recently approved antibiotics.
    Paterson DL
    Curr Opin Pharmacol; 2006 Oct; 6(5):486-90. PubMed ID: 16904377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison.
    Carter JD; Valeriano J; Vasey FB
    J Rheumatol; 2004 Oct; 31(10):1973-80. PubMed ID: 15468362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M; Mejía GI; Trujillo H; Robledo J
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
    Song JH; Ko KS; Lee MY; Park S; Baek JY; Lee JY; Heo ST; Kwon KT; Ryu SY; Oh WS; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of cerebrospinal isolates from patients with meningitis.
    Liskova A; Benca J; Kalavsky E; Kovac M; Rudinsky B; Ondrusova A; Kiwou M
    Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():5-6. PubMed ID: 18030262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive rifampin therapy for central nervous system staphylococcal infections.
    Brackbill ML; Brophy GM
    Ann Pharmacother; 2001 Jun; 35(6):765-9. PubMed ID: 11408996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.